• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类胸腺细胞表面抗原T6、T9和T10的生化研究。

Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10.

作者信息

Terhorst C, van Agthoven A, LeClair K, Snow P, Reinherz E, Schlossman S

出版信息

Cell. 1981 Mar;23(3):771-80. doi: 10.1016/0092-8674(81)90441-4.

DOI:10.1016/0092-8674(81)90441-4
PMID:7013988
Abstract

Three human thymic cell-surface antigens T6, T9 and T10, previously defined by monoclonal antibodies, were analyzed using immunoprecipitation techniques. The antigen T6 was found to be a 49,000 dalton glycoprotein, which is associated with beta 2-microglobulin, the small subunit (12,000 daltons) of the HLA-A, -B, and -C antigens. The target antigen for the monoclonal reagent anti-T9 was found to be a glycoprotein of 94,000 daltons, which appears as a disulfide-linked dimer of 190,000 daltons on the cell surface. The antigen precipitated by the anti-T10 antibody is a 45,000 dalton glycoprotein. We present preliminary evidence that all three cell-surface proteins may be integral membrane proteins. These findings, in addition to the distribution patterns, suggest that the T6 antigen is the human homolog of the murine thymus leukemia (TL) antigen.

摘要

利用免疫沉淀技术分析了先前由单克隆抗体定义的三种人类胸腺细胞表面抗原T6、T9和T10。发现抗原T6是一种49000道尔顿的糖蛋白,它与β2-微球蛋白相关,β2-微球蛋白是HLA-A、-B和-C抗原的小亚基(12000道尔顿)。发现单克隆试剂抗-T9的靶抗原是一种94000道尔顿的糖蛋白,在细胞表面它表现为190000道尔顿的二硫键连接的二聚体。抗-T10抗体沉淀的抗原是一种45000道尔顿的糖蛋白。我们提供了初步证据表明这三种细胞表面蛋白可能都是整合膜蛋白。这些发现,除了分布模式外,还表明T6抗原是小鼠胸腺白血病(TL)抗原的人类同源物。

相似文献

1
Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10.人类胸腺细胞表面抗原T6、T9和T10的生化研究。
Cell. 1981 Mar;23(3):771-80. doi: 10.1016/0092-8674(81)90441-4.
2
Biochemical characterization of the human T6 antigen: a comparison between T6 and murine TL.人T6抗原的生化特性:T6与小鼠TL的比较
Mol Immunol. 1984 Oct;21(10):821-9. doi: 10.1016/0161-5890(84)90135-4.
3
Identification of a rabbit class I-like thymocyte-specific antigen.一种兔类I型胸腺细胞特异性抗原的鉴定。
J Immunol. 1987 May 15;138(10):3352-9.
4
Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5.人类T淋巴细胞分化抗原T4和T5的生化分析。
Science. 1980 Jul 25;209(4455):520-1. doi: 10.1126/science.6967228.
5
The thymic differentiation markers T6 and M241 are two unusual MHC class I antigens.胸腺分化标志物T6和M241是两种不同寻常的MHC I类抗原。
J Immunol. 1983 Aug;131(2):851-5.
6
Biochemical comparison of the T6 antigen and HLA-A,B antigens.T6抗原与HLA - A、B抗原的生化比较。
Hum Immunol. 1983 Jan;6(1):13-30. doi: 10.1016/0198-8859(83)90070-8.
7
Covalent association between human thymus leukemia-like antigens and CD8(Tp32) molecules.人类胸腺白血病样抗原与CD8(Tp32)分子之间的共价结合。
J Immunol. 1985 Jun;134(6):4250-4.
8
A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin.一种识别与β2-微球蛋白相关的人类胸腺白血病样抗原的单克隆抗体。
Eur J Immunol. 1982 Aug;12(8):676-81. doi: 10.1002/eji.1830120810.
9
Further biochemical characterization of the human thymocyte differentiation antigen T6.人类胸腺细胞分化抗原T6的进一步生化特性研究
J Immunol. 1982 Jan;128(1):426-32.
10
Association between the human thymic differentiation antigens T6 and T8.人类胸腺分化抗原T6与T8之间的关联。
Eur J Immunol. 1985 May;15(5):529-32. doi: 10.1002/eji.1830150520.

引用本文的文献

1
CAR-T cell therapy for cancer: current challenges and future directions.用于癌症治疗的嵌合抗原受体T细胞疗法:当前挑战与未来方向
Signal Transduct Target Ther. 2025 Jul 4;10(1):210. doi: 10.1038/s41392-025-02269-w.
2
Enzymology of Ca-Mobilizing Second Messengers Derived from NAD: From NAD Glycohydrolases to (Dual) NADPH Oxidases.钙动员第二信使的酶学研究源于 NAD:从 NAD 糖水解酶到(双)NADPH 氧化酶。
Cells. 2023 Feb 20;12(4):675. doi: 10.3390/cells12040675.
3
Targeting CD38 for acute leukemia.以CD38为靶点治疗急性白血病。
Front Oncol. 2022 Oct 12;12:1007783. doi: 10.3389/fonc.2022.1007783. eCollection 2022.
4
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.肿瘤浸润 B 淋巴细胞和浆细胞对三阴性乳腺癌的预后价值。
Breast Cancer. 2021 Jul;28(4):904-914. doi: 10.1007/s12282-021-01227-y. Epub 2021 Feb 25.
5
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model.基于 CD38 受体表达和功能的抗 CD38 治疗新见解:多发性骨髓瘤模型。
Cells. 2020 Dec 11;9(12):2666. doi: 10.3390/cells9122666.
6
The Circular Life of Human CD38: From Basic Science to Clinics and Back.人类 CD38 的循环生命:从基础科学到临床再到基础科学。
Molecules. 2020 Oct 21;25(20):4844. doi: 10.3390/molecules25204844.
7
CD38: T Cell Immuno-Metabolic Modulator.CD38:T 细胞免疫代谢调节剂。
Cells. 2020 Jul 17;9(7):1716. doi: 10.3390/cells9071716.
8
OMIP-064: A 27-Color Flow Cytometry Panel to Detect and Characterize Human NK Cells and Other Innate Lymphoid Cell Subsets, MAIT Cells, and γδ T Cells.OMIP-064:用于检测和鉴定人自然杀伤细胞及其他固有淋巴细胞亚群、黏膜相关恒定T细胞和γδT细胞的27色流式细胞术检测板
Cytometry A. 2020 Oct;97(10):1019-1023. doi: 10.1002/cyto.a.24031. Epub 2020 May 16.
9
Roles of CD38 in the Immune Response to Infection.CD38 在感染免疫反应中的作用。
Cells. 2020 Jan 16;9(1):228. doi: 10.3390/cells9010228.
10
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.多发性骨髓瘤中抗 CD38 达雷妥尤单抗耐药的机制。
Cells. 2020 Jan 9;9(1):167. doi: 10.3390/cells9010167.